Silverberg Bernstein Capital Management LLC Neogenomics Inc Transaction History
Silverberg Bernstein Capital Management LLC
- $146 Billion
- Q2 2025
A detailed history of Silverberg Bernstein Capital Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 40,380 shares of NEO stock, worth $245,510. This represents 0.2% of its overall portfolio holdings.
Number of Shares
40,380
Previous 21,080
91.56%
Holding current value
$245,510
Previous $200 Million
47.55%
% of portfolio
0.2%
Previous 0.19%
Shares
5 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
129MCall Options Held
1.1MPut Options Held
296K-
Black Rock Inc. New York, NY19.7MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$85.9 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$45.2 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$41.6 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$31.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $765M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...